Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00697151 · ClinicalTrials.gov registry record · Phase 4
Patent Foramen Ovale in Cryptogenic Stroke Study
A Phase 4 study of Ischemic Stroke and Patent Foramen Ovale, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 630
- Enrollment target
- 1
- Study location
NCT00697151: Completed Phase 4 study of Ischemic Stroke and Patent Foramen Ovale, sponsored by Columbia University.
NCT00697151 is a Phase 4 study of Ischemic Stroke and Patent Foramen Ovale that has completed, run by Columbia University. The registered enrollment target is 630 participants, below the 1,454-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00697151, a Phase 4 study of Ischemic Stroke and Patent Foramen Ovale, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 630 participants
- Enrollment target
- 1
- Study location
Study Summary
The study sought to assess the rate of recurrent stroke and death in stroke patients with a patent foramen ovale randomized to treatment with warfarin or aspirin. This was a multicenter study conducted at 48 U.S. Institutions.
Conditions Studied
Interventions
- DRUG Aspirin
- DRUG Warfarin
Study Locations (1)
New York
- Columbia College of Physicians and Surgeons - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 630 participants |
| Start Date | 1993-06 |
| Est. Completion | 2000-06 |
| Phase | Phase 4 |
What the finished NCT00697151 record still lists
NCT00697151 is an interventional study that assigns participants to a tested intervention. The registered 630 participants enrollment target is mid-sized for trials with a published cap, below the 1,454-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (57% lower).
The record links to 2 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which Aspirin is the first listed.
NCT00697151 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00697151 about?
NCT00697151 is a clinical study titled "Patent Foramen Ovale in Cryptogenic Stroke Study". The study sought to assess the rate of recurrent stroke and death in stroke patients with a patent foramen ovale randomized to treatment with warfarin or aspirin. This was a multicenter study conducted at 48 U.S. Institutions.
What is the current status of trial NCT00697151?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 630 participants. The study started on 1993-06. Estimated completion is 2000-06.
What conditions does trial NCT00697151 study?
This clinical trial studies the following conditions: Ischemic Stroke, Patent Foramen Ovale.
What interventions are being tested in trial NCT00697151?
The interventions under investigation include: Aspirin (DRUG), Warfarin (DRUG).
Who is sponsoring clinical trial NCT00697151?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00697151 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00697151's enrollment target sits among peer trials
630 13th of 66 higher than 54 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Quality Improvement in Stroke Prevention (QUISP)
COMPLETED · Phase 4
-
Assess the Penumbra System in the Treatment of Acute Stroke
COMPLETED · Phase 4
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Transitions of Care for Stroke Patients
RECRUITING
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia